What is the dosage of Amvuttra?

Amvuttra is available in 1 dosages, including 50 mg/ml Prefilled Syringe 0.5 ml

What does Amvuttra treat?

Amvuttra treats Polyneuropathies and Familial Amyloid Neuropathies

What is Amvuttra made of?

Amvuttra contains vutrisiran which is a undefined

How is Amvuttra administered?

Amvuttra is administered as a Injectable

What is Amvuttra mechanism of action?

Amvuttra mechanism of action is

Dosage & Administration Drug label Samples Prior authorization Financial assistance

Patient education

Amvuttra

(vutrisiran)

0.5 ML vutrisiran 50 MG/ML Prefilled Syringe [Amvuttra]

NO BLACK BOX WARNING

Dosage & administration

* The recommended dosage of AMVUTTRA is 25 mg administered by subcutaneous injection once every 3 months.
* AMVUTTRA is for subcutaneous use only and should be administered by a healthcare professional.

drug label

Amvuttra prescribing information

Have more Amvuttra questions?

Submit MSL Request

Learn More

Need to report an Amvuttra issue?

ONLINE FORMReport adverse event

Learn More

samples

Request Amvuttra samples

NOT PROVIDED BY BRANDView Online Sample Form

Learn More

prior authorization

Amvuttra Prior authorization resources

Complete Letter of Medical Necessity

NOT PROVIDED BY BRANDCoverage Authorization Request

NOT PROVIDED BY BRANDCoverage Authorization Appeals

Learn More

Benefits investigation

Amvuttra Start Form

Learn More

Reimbursement help (FRM)

NOT PROVIDED BY BRANDReimbursement help (FRM) resources

Learn More

financial assistance

Amvuttra Financial assistance options

Co-pay savings program

commercial only

NOT PROVIDED BY BRANDEnroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

commercial only

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

under insured

no insurance

goverment insurance

65+

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Amvuttra Patient education

Getting started on Amvuttra

NOT PROVIDED BY BRANDInstructions For Use - Polyneuropathy due to Hereditary Transthyretin-mediated Amyloidosis (hATTR amyloidosis)

Patient toolkit

Patient Brochure

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Patient Resources

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

About Amvuttra

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Learn More

Can't find what you're looking for?

Our trained staff can help you:

Please note:

Access to a Field Reimbursement Manager (FRM) or Medical Science Liaison (MSL) varies by brand and may require talking with your rep first.
Samples are provided at the discretion of the brand.
We are unable to collect Protected Health Information (PHI), fill out forms, or submit them on your behalf.

Amvuttra

Dosage & administration

drug label

Amvuttra prescribing information

Have more Amvuttra questions?

Need to report an Amvuttra issue?

samples

Request Amvuttra samples

Is my patient elegible for Amvuttra samples?

How do I find out who my Amvuttra rep is?

prior authorization

Amvuttra Prior authorization resources

Benefits investigation

Reimbursement help (FRM)

financial assistance

Amvuttra Financial assistance options

Co-pay savings program

Overview

Patient benefit

Patient eligibility

How to sign up

Bridge program

Overview

Patient benefit

Patient eligibility

How to sign up

Foundation programs

Overview

Patient benefit

Patient eligibility

How to sign up

patient education

Amvuttra Patient education

Getting started on Amvuttra

Patient toolkit

Can't find what you're looking for?